Connie Newman, MD is a Board-certified endocrinologist and Adjunct Associate Professor of Medicine at New York University School of Medicine. She has expertise in large cardiovascular outcomes trials of statins, statin safety, and the management of lipid disorders and diabetes. She is an attending physician at the Endocrinology and Diabetes Clinic of the Manhattan VA Hospital.
Dr. Newman has worked on several large randomized cardiovascular outcomes trials, including the Collaborative Atorvastatin Diabetes Study (CARDS) in patients with type 2 diabetes, and the Stroke Prevention by Aggressive Reduction in Cholesterol (SPARCL) trial in patients with a history of stroke or TIA. She also participated in the analysis of safety data from the SEARCH trial which compared simvastatin 80 mg versus 20 mg in about 12000 patients with a history of myocardial infarction. Dr. Newman is a member of the Cholesterol Treatment Trialists’ Collaboration, and an author of the meta-analysis of cancer events and cancer death in 170,000 participants in 27 trials of statins.
She is Chair of the Special Programs Committee of the Endocrine Society, and a member of the Women's Leadership Committee of the Arteriosclerosis, Thrombosis and Vascular Biology (ATVB) Council of the American Heart Association. She is also a member of the Membership Committee and Graduate Medical Education Committee of the National Lipid Association.